Publications by authors named "Shahram Jacobs"

Claim this Profile
S
Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study.
Kim A Papp, Shahram Jacobs, Howard Sofen, Michael Bukhalo, Elisa Muscianisi

J Am Acad Dermatolยท October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis